Success Metrics

Clinical Success Rate
100.0%

Based on 3 completed trials

Completion Rate
100%(3/3)
Active Trials
1(17%)
Results Posted
0%(0 trials)

Phase Distribution

Ph phase_2
4
67%
Ph not_applicable
2
33%

Phase Distribution

0

Early Stage

4

Mid Stage

0

Late Stage

Phase Distribution6 total trials
Phase 2Efficacy & side effects
4(66.7%)
N/ANon-phased studies
2(33.3%)

Highest Phase Reached

Phase 2

Trial Status & Enrollment

Completion Rate

100.0%

3 of 3 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

1

trials recruiting

Total Trials

6

all time

Status Distribution
Active(2)
Completed(3)
Other(1)

Detailed Status

Completed3
Active, not recruiting1
Not yet recruiting1
unknown1

Development Timeline

Analytics

Development Status

Total Trials
6
Active
1
Success Rate
100.0%
Most Advanced
Phase 2

Trials by Phase

Phase 24 (66.7%)
N/A2 (33.3%)

Trials by Status

active_not_recruiting117%
not_yet_recruiting117%
unknown117%
completed350%

Recent Activity

1 active trials
Showing 5 of 6
not_yet_recruitingnot_applicable

ReneuRx™ (Nerve Selective Therapy) Utilized in Lateral Hip Pain

NCT07568015
active_not_recruitingnot_applicable

INJECTABLE COLD ENERGY THERAPY FOR THE MANAGEMENT OF CHRONIC PAIN ASSOCIATED WITH OSTEOARTHRITIS OF THE KNEE

NCT06700109
unknownphase_2

Injection of Ranibizumab Versus Combination of Ranibizumab and Triamcinolone Acetate for (CRVO)

NCT04460001
completedphase_2

Open Label Extension of a Clinical Trial of Intravitreal Triamcinolone for Diabetic Macular Oedema-TDMX Study

NCT00148330
completedphase_2

A Multicentre Randomised Clinical Trial of Laser Treatment Plus Intravitreal Triamcinolone for Diabetic Macular Oedema

NCT00148265
View all 6 trials

Clinical Trials (6)

Showing 6 of 6 trials
NCT07568015Not Applicable

ReneuRx™ (Nerve Selective Therapy) Utilized in Lateral Hip Pain

Not Yet Recruiting
NCT06700109Not Applicable

INJECTABLE COLD ENERGY THERAPY FOR THE MANAGEMENT OF CHRONIC PAIN ASSOCIATED WITH OSTEOARTHRITIS OF THE KNEE

Active Not Recruiting
NCT04460001Phase 2

Injection of Ranibizumab Versus Combination of Ranibizumab and Triamcinolone Acetate for (CRVO)

Unknown
NCT00148330Phase 2

Open Label Extension of a Clinical Trial of Intravitreal Triamcinolone for Diabetic Macular Oedema-TDMX Study

Completed
NCT00148265Phase 2

A Multicentre Randomised Clinical Trial of Laser Treatment Plus Intravitreal Triamcinolone for Diabetic Macular Oedema

Completed
NCT00167518Phase 2

Intravitreal Triamcinolone for Clinically Significant Diabetic Macular Oedema That Persists After Laser Treatment (TDMO)

Completed

All 6 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
6